Importer of Controlled Substances Application: Stepan Company, 11623-11624 [2025-03766]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 45 / Monday, March 10, 2025 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–618–619 and
731–TA–1441–1444 (Review)]
Carbon and Alloy Steel Threaded Rod
From China, India, Taiwan, and
Thailand; Scheduling of Expedited
Five-Year Reviews
United States International
Trade Commission.
ACTION: Notice.
AGENCY:
The Commission hereby gives
notice of the scheduling of expedited
reviews pursuant to the Tariff Act of
1930 (‘‘the Act’’) to determine whether
revocation of the antidumping duty and
countervailing duty orders on carbon
and alloy steel threaded rod from China,
India, Taiwan, and Thailand would be
likely to lead to continuation or
recurrence of material injury within a
reasonably foreseeable time.
DATES: February 4, 2025.
FOR FURTHER INFORMATION CONTACT:
Jesse Sanchez (202) 205–2402, Office of
Investigations, U.S. International Trade
Commission, 500 E Street SW,
Washington, DC 20436. Hearingimpaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov). The public record for
this proceeding may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION:
Background.—On February 4, 2025,
the Commission determined that the
domestic interested party group
response to its notice of institution (89
FR 87409, November 1, 2024) of the
subject five-year reviews was adequate
and that the respondent interested party
group response was inadequate. The
Commission did not find any other
circumstances that would warrant
conducting full reviews.1 Accordingly,
the Commission determined that it
would conduct expedited reviews
pursuant to section 751(c)(3) of the Act
(19 U.S.C. 1675(c)(3)).
For further information concerning
the conduct of these reviews and rules
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
1A
record of the Commissioners’ votes, the
Commission’s statement on adequacy, and any
individual Commissioner’s statements will be
available from the Office of the Secretary and at the
Commission’s website.
VerDate Sep<11>2014
16:11 Mar 07, 2025
Jkt 265001
of general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
Staff report.—A staff report containing
information concerning the subject
matter of the reviews has been placed in
the nonpublic record, and will be made
available to persons on the
Administrative Protective Order service
list for these reviews on May 14, 2025.
A public version will be issued
thereafter, pursuant to § 207.62(d)(4) of
the Commission’s rules.
Written submissions.—As provided in
§ 207.62(d) of the Commission’s rules,
interested parties that are parties to the
reviews and that have provided
individually adequate responses to the
notice of institution,2 and any party
other than an interested party to the
reviews may file written comments with
the Secretary on what determination the
Commission should reach in the
reviews. Comments are due on or before
5:15 p.m. on May 22, 2025 and may not
contain new factual information. Any
person that is neither a party to the fiveyear reviews nor an interested party
may submit a brief written statement
(which shall not contain any new
factual information) pertinent to the
reviews by May 22, 2025. However,
should the Department of Commerce
(‘‘Commerce’’) extend the time limit for
its completion of the final results of its
reviews, the deadline for comments
(which may not contain new factual
information) on Commerce’s final
results is three business days after the
issuance of Commerce’s results. If
comments contain business proprietary
information (BPI), they must conform
with the requirements of §§ 201.6,
207.3, and 207.7 of the Commission’s
rules. The Commission’s Handbook on
Filing Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
In accordance with §§ 201.16(c) and
207.3 of the rules, each document filed
by a party to the reviews must be served
on all other parties to the reviews (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
2 The Commission has found the response
submitted on behalf of Bay Standard Manufacturing
Inc. and Vulcan Threaded Products Manufacturing
to be adequate. Comments from other interested
parties will not be accepted (see 19 CFR
207.62(d)(2)).
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
11623
Determination.—The Commission has
determined these reviews are
extraordinarily complicated and
therefore has determined to exercise its
authority to extend the review period by
up to 90 days pursuant to 19 U.S.C.
1675(c)(5)(B).
Authority: These reviews are being
conducted under authority of title VII of
the Act; this notice is published
pursuant to § 207.62 of the
Commission’s rules.
By order of the Commission.
Issued: March 5, 2025.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2025–03773 Filed 3–7–25; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1506]
Importer of Controlled Substances
Application: Stepan Company
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Stepan Company has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 9, 2025. Such persons
may also file a written request for a
hearing on the application on or before
April 9, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
DATES:
E:\FR\FM\10MRN1.SGM
10MRN1
11624
Federal Register / Vol. 90, No. 45 / Monday, March 10, 2025 / Notices
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on January 31, 2025,
Stepan Company, 100 West Hunter
Avenue, Maywood, New Jersey 07607–
1021 applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
Controlled substance
Coca Leaves ...................
Drug
code
Schedule
9040
II
The company plans to import the
listed controlled substance(s) to bulk
manufacture other controlled substances
for distribution to its customers. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–03766 Filed 3–7–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2012–0010]
khammond on DSK9W7S144PROD with NOTICES
1,2-Dibromo-3-Chloropane (DBCP)
Standard; Extension of the Office of
Management and Budget’s (OMB)
Approval of Information Collection
(Paperwork) Requirements
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Request for public comments.
AGENCY:
OSHA solicits public
comments concerning the proposal to
extend the Office of Management and
Budget’s (OMB) approval of the
SUMMARY:
VerDate Sep<11>2014
16:11 Mar 07, 2025
Jkt 265001
information collection requirements
specified in the 1,2-Dibromo-3Chloropane (DBCP) Standard.
DATES: Comments must be submitted
(postmarked, sent, or received) by May
9, 2025.
ADDRESSES:
Electronically: You may submit
comments and attachments
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
instructions online for submitting
comments.
Docket: To read or download
comments or other material in the
docket, go to https://
www.regulations.gov. Documents in the
docket are listed in the https://
www.regulations.gov index; however,
some information (e.g., copyrighted
material) is not publicly available to
read or download through the websites.
All submissions, including copyrighted
material, are available for inspection
through the OSHA Docket Office.
Contact the OSHA Docket Office at (202)
693–2350 (TTY (877) 889–5627) for
assistance in locating docket
submissions.
Instructions: All submissions must
include the agency name and OSHA
docket number (OSHA–2012–0010) for
the Information Collection Request
(ICR). OSHA will place all comments,
including any personal information, in
the public docket, which may be made
available online. Therefore, OSHA
cautions interested parties about
submitting personal information such as
social security numbers and birthdates.
For further information on submitting
comments, see the ‘‘Public
Participation’’ heading in the section of
this notice titled SUPPLEMENTARY
INFORMATION.
FOR FURTHER INFORMATION CONTACT:
Seleda Perryman, Directorate of
Standards and Guidance, OSHA, U.S.
Department of Labor; telephone (202)
693–2222.
SUPPLEMENTARY INFORMATION:
I. Background
The Department of Labor, as part of
the continuing effort to reduce
paperwork and respondent (i.e.,
employer) burden, conducts a
preclearance consultation program to
provide the public with an opportunity
to comment on proposed and
continuing information collection
requirements in accordance with the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3506(c)(2)(A)). This program
ensures that information is in the
desired format, reporting burden (time
and costs) is minimal, the collection
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
instruments are clearly understood, and
OSHA’s estimate of the information
collection burden is accurate. The
Occupational Safety and Health Act of
1970 (OSH Act) (29 U.S.C. 651 et seq.)
authorizes information collection by
employers as necessary or appropriate
for enforcement of the OSH Act or for
developing information regarding the
causes and prevention of occupational
injuries, illnesses, and accidents (29
U.S.C. 657). The OSH Act also requires
that OSHA obtain such information
with minimum burden upon employers,
especially those operating small
businesses, and to reduce to the
maximum extent feasible unnecessary
duplication of effort in obtaining
information (29 U.S.C. 657).
The following sections describe who
uses the information collected under
each requirement, as well as how they
use it. The purpose of these
requirements is to reduce employees’
risk of death or serious injury by
ensuring that employment has been
tested and is in safe operating condition.
The information collection
requirements in the DBCP Standard
provide protection for workers from the
adverse health effects associated with
exposure to DBCP. In this regard, the
DBCP Standard requires employers to:
monitor workers’ exposure to DBCP;
monitor worker health and provide
workers with information about their
exposure and the health effects of
exposure to DBCP.
II. Special Issues for Comment
OSHA has a particular interest in
comments on the following issues:
• Whether the proposed information
collection requirements are necessary
for the proper performance of the
agency’s functions to protect workers,
including whether the information is
useful;
• The accuracy of OSHA’s estimate of
the burden (time and costs) of the
information collection requirements,
including the validity of the
methodology and assumptions used;
• The quality, utility, and clarity of
the information collected; and
• Ways to minimize the burden on
employers who must comply; for
example, by using automated or other
technological information, and
transmission techniques.
III. Proposed Actions
OSHA is requesting that OMB extend
the approval of the information
collection requirements contained in the
1,2-Dibromo-3-Chloropane (DBCP)
Standard. The agency is requesting for
the burden of one hour to remain the
same.
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 90, Number 45 (Monday, March 10, 2025)]
[Notices]
[Pages 11623-11624]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-03766]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1506]
Importer of Controlled Substances Application: Stepan Company
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Stepan Company has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 9, 2025. Such persons may also file a written request for a
hearing on the application on or before April 9, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
[[Page 11624]]
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on January 31, 2025, Stepan Company, 100 West Hunter
Avenue, Maywood, New Jersey 07607-1021 applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Coca Leaves............................. 9040 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance(s) to
bulk manufacture other controlled substances for distribution to its
customers. No other activity for this drug code is authorized for this
registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-03766 Filed 3-7-25; 8:45 am]
BILLING CODE P
